139 related articles for article (PubMed ID: 19694806)
41. Posttranslational removal of α-dystroglycan N terminus by PC5/6 cleavage is important for uterine preparation for embryo implantation in women.
Heng S; Paule SG; Li Y; Rombauts LJ; Vollenhoven B; Salamonsen LA; Nie G
FASEB J; 2015 Sep; 29(9):4011-22. PubMed ID: 26077903
[TBL] [Abstract][Full Text] [Related]
42. Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.
Zhang P; Hu H
Glycobiology; 2012 Feb; 22(2):235-47. PubMed ID: 21930648
[TBL] [Abstract][Full Text] [Related]
43. A tumor suppressor function of laminin-binding alpha-dystroglycan.
Bao X; Fukuda M
Methods Enzymol; 2010; 479():387-96. PubMed ID: 20816178
[TBL] [Abstract][Full Text] [Related]
44. Distinct requirements for heparin and alpha-dystroglycan binding revealed by structure-based mutagenesis of the laminin alpha2 LG4-LG5 domain pair.
Wizemann H; Garbe JH; Friedrich MV; Timpl R; Sasaki T; Hohenester E
J Mol Biol; 2003 Sep; 332(3):635-42. PubMed ID: 12963372
[TBL] [Abstract][Full Text] [Related]
45. Cys669-Cys713 disulfide bridge formation is a key to dystroglycan cleavage and subunit association.
Watanabe N; Sasaoka T; Noguchi S; Nishino I; Tanaka T
Genes Cells; 2007 Jan; 12(1):75-88. PubMed ID: 17212656
[TBL] [Abstract][Full Text] [Related]
46. HNK-1 sulfotransferase-dependent sulfation regulating laminin-binding glycans occurs in the post-phosphoryl moiety on α-dystroglycan.
Nakagawa N; Takematsu H; Oka S
Glycobiology; 2013 Sep; 23(9):1066-74. PubMed ID: 23723439
[TBL] [Abstract][Full Text] [Related]
47. Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies.
Endo T
Acta Myol; 2005 Oct; 24(2):64-9. PubMed ID: 16550917
[TBL] [Abstract][Full Text] [Related]
48. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.
Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP
J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275
[TBL] [Abstract][Full Text] [Related]
49. Sarcolemma instability during mechanical activity in Largemyd cardiac myocytes with loss of dystroglycan extracellular matrix receptor function.
Kabaeva Z; Meekhof KE; Michele DE
Hum Mol Genet; 2011 Sep; 20(17):3346-55. PubMed ID: 21628317
[TBL] [Abstract][Full Text] [Related]
50. Analysis of the GFP-labelled β-dystroglycan interactome in HEK-293 transfected cells reveals novel intracellular networks.
Sciandra F; Desiderio C; Vincenzoni F; Viscuso S; Bozzi M; Hübner W; Jimenez-Gutierrez GE; Cisneros B; Brancaccio A
Biochem Biophys Res Commun; 2024 Apr; 703():149656. PubMed ID: 38364681
[TBL] [Abstract][Full Text] [Related]
51. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.
Côté PD; Moukhles H; Lindenbaum M; Carbonetto S
Nat Genet; 1999 Nov; 23(3):338-42. PubMed ID: 10610181
[TBL] [Abstract][Full Text] [Related]
52. Molecular dissection of the alpha-dystroglycan- and integrin-binding sites within the globular domain of human laminin-10.
Ido H; Harada K; Futaki S; Hayashi Y; Nishiuchi R; Natsuka Y; Li S; Wada Y; Combs AC; Ervasti JM; Sekiguchi K
J Biol Chem; 2004 Mar; 279(12):10946-54. PubMed ID: 14701821
[TBL] [Abstract][Full Text] [Related]
53. The structure of the N-terminal region of murine skeletal muscle alpha-dystroglycan discloses a modular architecture.
Bozic D; Sciandra F; Lamba D; Brancaccio A
J Biol Chem; 2004 Oct; 279(43):44812-6. PubMed ID: 15326183
[TBL] [Abstract][Full Text] [Related]
54. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.
Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP
Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576
[TBL] [Abstract][Full Text] [Related]
55. Insertion of a myc-tag within α-dystroglycan domains improves its biochemical and microscopic detection.
Morlacchi S; Sciandra F; Bigotti MG; Bozzi M; Hübner W; Galtieri A; Giardina B; Brancaccio A
BMC Biochem; 2012 Jul; 13():14. PubMed ID: 22835149
[TBL] [Abstract][Full Text] [Related]
56. Direct interaction of beta-dystroglycan with F-actin.
Chen YJ; Spence HJ; Cameron JM; Jess T; Ilsley JL; Winder SJ
Biochem J; 2003 Oct; 375(Pt 2):329-37. PubMed ID: 12892561
[TBL] [Abstract][Full Text] [Related]
57. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
[TBL] [Abstract][Full Text] [Related]
58. Muscular dystrophy associated with alpha-dystroglycan deficiency in Sphynx and Devon Rex cats.
Martin PT; Shelton GD; Dickinson PJ; Sturges BK; Xu R; LeCouteur RA; Guo LT; Grahn RA; Lo HP; North KN; Malik R; Engvall E; Lyons LA
Neuromuscul Disord; 2008 Dec; 18(12):942-52. PubMed ID: 18990577
[TBL] [Abstract][Full Text] [Related]
59. Genetic Engineering of Dystroglycan in Animal Models of Muscular Dystrophy.
Sciandra F; Bigotti MG; Giardina B; Bozzi M; Brancaccio A
Biomed Res Int; 2015; 2015():635792. PubMed ID: 26380289
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of the effect of a floxed Neo cassette within the dystroglycan (Dag1) gene.
Sciandra F; Scicchitano BM; Signorino G; Bigotti MG; Tavazzi B; Lombardi F; Bozzi M; Sica G; Giardina B; Blaess S; Brancaccio A
BMC Res Notes; 2017 Nov; 10(1):601. PubMed ID: 29157305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
